Request for Covid-19 Impact Assessment of this Report
The United States Meropenem Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Meropenem Injection market, reaching US$ million by the year 2028. As for the Europe Meropenem Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Meropenem Injection players cover Pfizer, AuroMedics, Sandoz, and Amneal Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Meropenem Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
0.25g/vial
0.5g/vial
1g/vial
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
AuroMedics
Sandoz
Amneal Pharmaceuticals
Sumitomo Dainippon Pharma
Fresenius Kabi
Mylan
Sagent Pharmaceuticals
Bionova Scientific
Macleods Pharmaceuticals
Johnlee Pharmaceuticals
Xinya Pharm
PKU HealthCare
United Laboratories
CSPC Group
Zhejiang Hisun Pharmaceutical
Luoxin Pharmaceutical
Hainan Haiyao Co., Ltd.
Shenzhen Haibin Pharmaceutical
Chongqin Shenghuaxi
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Meropenem Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Meropenem Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Meropenem Injection by Country/Region, 2017, 2022 & 2028
2.2 Meropenem Injection Segment by Type
2.2.1 0.25g/vial
2.2.2 0.5g/vial
2.2.3 1g/vial
2.3 Meropenem Injection Sales by Type
2.3.1 Global Meropenem Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Meropenem Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Meropenem Injection Sale Price by Type (2017-2022)
2.4 Meropenem Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Others
2.5 Meropenem Injection Sales by Application
2.5.1 Global Meropenem Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Meropenem Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Meropenem Injection Sale Price by Application (2017-2022)
3 Global Meropenem Injection by Company
3.1 Global Meropenem Injection Breakdown Data by Company
3.1.1 Global Meropenem Injection Annual Sales by Company (2020-2022)
3.1.2 Global Meropenem Injection Sales Market Share by Company (2020-2022)
3.2 Global Meropenem Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Meropenem Injection Revenue by Company (2020-2022)
3.2.2 Global Meropenem Injection Revenue Market Share by Company (2020-2022)
3.3 Global Meropenem Injection Sale Price by Company
3.4 Key Manufacturers Meropenem Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meropenem Injection Product Location Distribution
3.4.2 Players Meropenem Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Meropenem Injection by Geographic Region
4.1 World Historic Meropenem Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Meropenem Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Meropenem Injection Annual Revenue by Geographic Region
4.2 World Historic Meropenem Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Meropenem Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Meropenem Injection Annual Revenue by Country/Region
4.3 Americas Meropenem Injection Sales Growth
4.4 APAC Meropenem Injection Sales Growth
4.5 Europe Meropenem Injection Sales Growth
4.6 Middle East & Africa Meropenem Injection Sales Growth
5 Americas
5.1 Americas Meropenem Injection Sales by Country
5.1.1 Americas Meropenem Injection Sales by Country (2017-2022)
5.1.2 Americas Meropenem Injection Revenue by Country (2017-2022)
5.2 Americas Meropenem Injection Sales by Type
5.3 Americas Meropenem Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meropenem Injection Sales by Region
6.1.1 APAC Meropenem Injection Sales by Region (2017-2022)
6.1.2 APAC Meropenem Injection Revenue by Region (2017-2022)
6.2 APAC Meropenem Injection Sales by Type
6.3 APAC Meropenem Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Meropenem Injection by Country
7.1.1 Europe Meropenem Injection Sales by Country (2017-2022)
7.1.2 Europe Meropenem Injection Revenue by Country (2017-2022)
7.2 Europe Meropenem Injection Sales by Type
7.3 Europe Meropenem Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Meropenem Injection by Country
8.1.1 Middle East & Africa Meropenem Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Meropenem Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Meropenem Injection Sales by Type
8.3 Middle East & Africa Meropenem Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meropenem Injection
10.3 Manufacturing Process Analysis of Meropenem Injection
10.4 Industry Chain Structure of Meropenem Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meropenem Injection Distributors
11.3 Meropenem Injection Customer
12 World Forecast Review for Meropenem Injection by Geographic Region
12.1 Global Meropenem Injection Market Size Forecast by Region
12.1.1 Global Meropenem Injection Forecast by Region (2023-2028)
12.1.2 Global Meropenem Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Meropenem Injection Forecast by Type
12.7 Global Meropenem Injection Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Meropenem Injection Product Offered
13.1.3 Pfizer Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 AuroMedics
13.2.1 AuroMedics Company Information
13.2.2 AuroMedics Meropenem Injection Product Offered
13.2.3 AuroMedics Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AuroMedics Main Business Overview
13.2.5 AuroMedics Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Meropenem Injection Product Offered
13.3.3 Sandoz Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Amneal Pharmaceuticals
13.4.1 Amneal Pharmaceuticals Company Information
13.4.2 Amneal Pharmaceuticals Meropenem Injection Product Offered
13.4.3 Amneal Pharmaceuticals Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Amneal Pharmaceuticals Main Business Overview
13.4.5 Amneal Pharmaceuticals Latest Developments
13.5 Sumitomo Dainippon Pharma
13.5.1 Sumitomo Dainippon Pharma Company Information
13.5.2 Sumitomo Dainippon Pharma Meropenem Injection Product Offered
13.5.3 Sumitomo Dainippon Pharma Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sumitomo Dainippon Pharma Main Business Overview
13.5.5 Sumitomo Dainippon Pharma Latest Developments
13.6 Fresenius Kabi
13.6.1 Fresenius Kabi Company Information
13.6.2 Fresenius Kabi Meropenem Injection Product Offered
13.6.3 Fresenius Kabi Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Fresenius Kabi Main Business Overview
13.6.5 Fresenius Kabi Latest Developments
13.7 Mylan
13.7.1 Mylan Company Information
13.7.2 Mylan Meropenem Injection Product Offered
13.7.3 Mylan Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Mylan Main Business Overview
13.7.5 Mylan Latest Developments
13.8 Sagent Pharmaceuticals
13.8.1 Sagent Pharmaceuticals Company Information
13.8.2 Sagent Pharmaceuticals Meropenem Injection Product Offered
13.8.3 Sagent Pharmaceuticals Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sagent Pharmaceuticals Main Business Overview
13.8.5 Sagent Pharmaceuticals Latest Developments
13.9 Bionova Scientific
13.9.1 Bionova Scientific Company Information
13.9.2 Bionova Scientific Meropenem Injection Product Offered
13.9.3 Bionova Scientific Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Bionova Scientific Main Business Overview
13.9.5 Bionova Scientific Latest Developments
13.10 Macleods Pharmaceuticals
13.10.1 Macleods Pharmaceuticals Company Information
13.10.2 Macleods Pharmaceuticals Meropenem Injection Product Offered
13.10.3 Macleods Pharmaceuticals Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Macleods Pharmaceuticals Main Business Overview
13.10.5 Macleods Pharmaceuticals Latest Developments
13.11 Johnlee Pharmaceuticals
13.11.1 Johnlee Pharmaceuticals Company Information
13.11.2 Johnlee Pharmaceuticals Meropenem Injection Product Offered
13.11.3 Johnlee Pharmaceuticals Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Johnlee Pharmaceuticals Main Business Overview
13.11.5 Johnlee Pharmaceuticals Latest Developments
13.12 Xinya Pharm
13.12.1 Xinya Pharm Company Information
13.12.2 Xinya Pharm Meropenem Injection Product Offered
13.12.3 Xinya Pharm Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Xinya Pharm Main Business Overview
13.12.5 Xinya Pharm Latest Developments
13.13 PKU HealthCare
13.13.1 PKU HealthCare Company Information
13.13.2 PKU HealthCare Meropenem Injection Product Offered
13.13.3 PKU HealthCare Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 PKU HealthCare Main Business Overview
13.13.5 PKU HealthCare Latest Developments
13.14 United Laboratories
13.14.1 United Laboratories Company Information
13.14.2 United Laboratories Meropenem Injection Product Offered
13.14.3 United Laboratories Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 United Laboratories Main Business Overview
13.14.5 United Laboratories Latest Developments
13.15 CSPC Group
13.15.1 CSPC Group Company Information
13.15.2 CSPC Group Meropenem Injection Product Offered
13.15.3 CSPC Group Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 CSPC Group Main Business Overview
13.15.5 CSPC Group Latest Developments
13.16 Zhejiang Hisun Pharmaceutical
13.16.1 Zhejiang Hisun Pharmaceutical Company Information
13.16.2 Zhejiang Hisun Pharmaceutical Meropenem Injection Product Offered
13.16.3 Zhejiang Hisun Pharmaceutical Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Zhejiang Hisun Pharmaceutical Main Business Overview
13.16.5 Zhejiang Hisun Pharmaceutical Latest Developments
13.17 Luoxin Pharmaceutical
13.17.1 Luoxin Pharmaceutical Company Information
13.17.2 Luoxin Pharmaceutical Meropenem Injection Product Offered
13.17.3 Luoxin Pharmaceutical Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Luoxin Pharmaceutical Main Business Overview
13.17.5 Luoxin Pharmaceutical Latest Developments
13.18 Hainan Haiyao Co., Ltd.
13.18.1 Hainan Haiyao Co., Ltd. Company Information
13.18.2 Hainan Haiyao Co., Ltd. Meropenem Injection Product Offered
13.18.3 Hainan Haiyao Co., Ltd. Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Hainan Haiyao Co., Ltd. Main Business Overview
13.18.5 Hainan Haiyao Co., Ltd. Latest Developments
13.19 Shenzhen Haibin Pharmaceutical
13.19.1 Shenzhen Haibin Pharmaceutical Company Information
13.19.2 Shenzhen Haibin Pharmaceutical Meropenem Injection Product Offered
13.19.3 Shenzhen Haibin Pharmaceutical Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Shenzhen Haibin Pharmaceutical Main Business Overview
13.19.5 Shenzhen Haibin Pharmaceutical Latest Developments
13.20 Chongqin Shenghuaxi
13.20.1 Chongqin Shenghuaxi Company Information
13.20.2 Chongqin Shenghuaxi Meropenem Injection Product Offered
13.20.3 Chongqin Shenghuaxi Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Chongqin Shenghuaxi Main Business Overview
13.20.5 Chongqin Shenghuaxi Latest Developments
14 Research Findings and Conclusion
Table 1. Meropenem Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Meropenem Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.25g/vial
Table 4. Major Players of 0.5g/vial
Table 5. Major Players of 1g/vial
Table 6. Global Meropenem Injection Sales by Type (2017-2022) & (K Units)
Table 7. Global Meropenem Injection Sales Market Share by Type (2017-2022)
Table 8. Global Meropenem Injection Revenue by Type (2017-2022) & ($ million)
Table 9. Global Meropenem Injection Revenue Market Share by Type (2017-2022)
Table 10. Global Meropenem Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Meropenem Injection Sales by Application (2017-2022) & (K Units)
Table 12. Global Meropenem Injection Sales Market Share by Application (2017-2022)
Table 13. Global Meropenem Injection Revenue by Application (2017-2022)
Table 14. Global Meropenem Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Meropenem Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Meropenem Injection Sales by Company (2020-2022) & (K Units)
Table 17. Global Meropenem Injection Sales Market Share by Company (2020-2022)
Table 18. Global Meropenem Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Meropenem Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Meropenem Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Meropenem Injection Producing Area Distribution and Sales Area
Table 22. Players Meropenem Injection Products Offered
Table 23. Meropenem Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Meropenem Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Meropenem Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Meropenem Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Meropenem Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Meropenem Injection Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Meropenem Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Meropenem Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Meropenem Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Meropenem Injection Sales by Country (2017-2022) & (K Units)
Table 35. Americas Meropenem Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Meropenem Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Meropenem Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Meropenem Injection Sales by Type (2017-2022) & (K Units)
Table 39. Americas Meropenem Injection Sales Market Share by Type (2017-2022)
Table 40. Americas Meropenem Injection Sales by Application (2017-2022) & (K Units)
Table 41. Americas Meropenem Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Meropenem Injection Sales by Region (2017-2022) & (K Units)
Table 43. APAC Meropenem Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Meropenem Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Meropenem Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Meropenem Injection Sales by Type (2017-2022) & (K Units)
Table 47. APAC Meropenem Injection Sales Market Share by Type (2017-2022)
Table 48. APAC Meropenem Injection Sales by Application (2017-2022) & (K Units)
Table 49. APAC Meropenem Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Meropenem Injection Sales by Country (2017-2022) & (K Units)
Table 51. Europe Meropenem Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Meropenem Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Meropenem Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Meropenem Injection Sales by Type (2017-2022) & (K Units)
Table 55. Europe Meropenem Injection Sales Market Share by Type (2017-2022)
Table 56. Europe Meropenem Injection Sales by Application (2017-2022) & (K Units)
Table 57. Europe Meropenem Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Meropenem Injection Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Meropenem Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Meropenem Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Meropenem Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Meropenem Injection Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Meropenem Injection Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Meropenem Injection Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Meropenem Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Meropenem Injection
Table 67. Key Market Challenges & Risks of Meropenem Injection
Table 68. Key Industry Trends of Meropenem Injection
Table 69. Meropenem Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Meropenem Injection Distributors List
Table 72. Meropenem Injection Customer List
Table 73. Global Meropenem Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Meropenem Injection Sales Market Forecast by Region
Table 75. Global Meropenem Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Meropenem Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Meropenem Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Meropenem Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Meropenem Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Meropenem Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Meropenem Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Meropenem Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Meropenem Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Meropenem Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Meropenem Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Meropenem Injection Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Meropenem Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Meropenem Injection Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Meropenem Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Meropenem Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Meropenem Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Meropenem Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. Pfizer Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Meropenem Injection Product Offered
Table 95. Pfizer Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. AuroMedics Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. AuroMedics Meropenem Injection Product Offered
Table 100. AuroMedics Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. AuroMedics Main Business
Table 102. AuroMedics Latest Developments
Table 103. Sandoz Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Sandoz Meropenem Injection Product Offered
Table 105. Sandoz Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Sandoz Main Business
Table 107. Sandoz Latest Developments
Table 108. Amneal Pharmaceuticals Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Amneal Pharmaceuticals Meropenem Injection Product Offered
Table 110. Amneal Pharmaceuticals Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Amneal Pharmaceuticals Main Business
Table 112. Amneal Pharmaceuticals Latest Developments
Table 113. Sumitomo Dainippon Pharma Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Sumitomo Dainippon Pharma Meropenem Injection Product Offered
Table 115. Sumitomo Dainippon Pharma Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Sumitomo Dainippon Pharma Main Business
Table 117. Sumitomo Dainippon Pharma Latest Developments
Table 118. Fresenius Kabi Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Fresenius Kabi Meropenem Injection Product Offered
Table 120. Fresenius Kabi Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Fresenius Kabi Main Business
Table 122. Fresenius Kabi Latest Developments
Table 123. Mylan Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Mylan Meropenem Injection Product Offered
Table 125. Mylan Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Mylan Main Business
Table 127. Mylan Latest Developments
Table 128. Sagent Pharmaceuticals Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Sagent Pharmaceuticals Meropenem Injection Product Offered
Table 130. Sagent Pharmaceuticals Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Sagent Pharmaceuticals Main Business
Table 132. Sagent Pharmaceuticals Latest Developments
Table 133. Bionova Scientific Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Bionova Scientific Meropenem Injection Product Offered
Table 135. Bionova Scientific Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Bionova Scientific Main Business
Table 137. Bionova Scientific Latest Developments
Table 138. Macleods Pharmaceuticals Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Macleods Pharmaceuticals Meropenem Injection Product Offered
Table 140. Macleods Pharmaceuticals Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Macleods Pharmaceuticals Main Business
Table 142. Macleods Pharmaceuticals Latest Developments
Table 143. Johnlee Pharmaceuticals Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Johnlee Pharmaceuticals Meropenem Injection Product Offered
Table 145. Johnlee Pharmaceuticals Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Johnlee Pharmaceuticals Main Business
Table 147. Johnlee Pharmaceuticals Latest Developments
Table 148. Xinya Pharm Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 149. Xinya Pharm Meropenem Injection Product Offered
Table 150. Xinya Pharm Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Xinya Pharm Main Business
Table 152. Xinya Pharm Latest Developments
Table 153. PKU HealthCare Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 154. PKU HealthCare Meropenem Injection Product Offered
Table 155. PKU HealthCare Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. PKU HealthCare Main Business
Table 157. PKU HealthCare Latest Developments
Table 158. United Laboratories Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 159. United Laboratories Meropenem Injection Product Offered
Table 160. United Laboratories Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. United Laboratories Main Business
Table 162. United Laboratories Latest Developments
Table 163. CSPC Group Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 164. CSPC Group Meropenem Injection Product Offered
Table 165. CSPC Group Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. CSPC Group Main Business
Table 167. CSPC Group Latest Developments
Table 168. Zhejiang Hisun Pharmaceutical Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 169. Zhejiang Hisun Pharmaceutical Meropenem Injection Product Offered
Table 170. Zhejiang Hisun Pharmaceutical Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. Zhejiang Hisun Pharmaceutical Main Business
Table 172. Zhejiang Hisun Pharmaceutical Latest Developments
Table 173. Luoxin Pharmaceutical Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 174. Luoxin Pharmaceutical Meropenem Injection Product Offered
Table 175. Luoxin Pharmaceutical Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 176. Luoxin Pharmaceutical Main Business
Table 177. Luoxin Pharmaceutical Latest Developments
Table 178. Hainan Haiyao Co., Ltd. Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 179. Hainan Haiyao Co., Ltd. Meropenem Injection Product Offered
Table 180. Hainan Haiyao Co., Ltd. Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 181. Hainan Haiyao Co., Ltd. Main Business
Table 182. Hainan Haiyao Co., Ltd. Latest Developments
Table 183. Shenzhen Haibin Pharmaceutical Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 184. Shenzhen Haibin Pharmaceutical Meropenem Injection Product Offered
Table 185. Shenzhen Haibin Pharmaceutical Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 186. Shenzhen Haibin Pharmaceutical Main Business
Table 187. Shenzhen Haibin Pharmaceutical Latest Developments
Table 188. Chongqin Shenghuaxi Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors
Table 189. Chongqin Shenghuaxi Meropenem Injection Product Offered
Table 190. Chongqin Shenghuaxi Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 191. Chongqin Shenghuaxi Main Business
Table 192. Chongqin Shenghuaxi Latest Developments
List of Figures
Figure 1. Picture of Meropenem Injection
Figure 2. Meropenem Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meropenem Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Meropenem Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Meropenem Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.25g/vial
Figure 10. Product Picture of 0.5g/vial
Figure 11. Product Picture of 1g/vial
Figure 12. Global Meropenem Injection Sales Market Share by Type in 2021
Figure 13. Global Meropenem Injection Revenue Market Share by Type (2017-2022)
Figure 14. Meropenem Injection Consumed in Hospital
Figure 15. Global Meropenem Injection Market: Hospital (2017-2022) & (K Units)
Figure 16. Meropenem Injection Consumed in Clinics
Figure 17. Global Meropenem Injection Market: Clinics (2017-2022) & (K Units)
Figure 18. Meropenem Injection Consumed in Others
Figure 19. Global Meropenem Injection Market: Others (2017-2022) & (K Units)
Figure 20. Global Meropenem Injection Sales Market Share by Application (2017-2022)
Figure 21. Global Meropenem Injection Revenue Market Share by Application in 2021
Figure 22. Meropenem Injection Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Meropenem Injection Revenue Market Share by Company in 2021
Figure 24. Global Meropenem Injection Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Meropenem Injection Revenue Market Share by Geographic Region in 2021
Figure 26. Global Meropenem Injection Sales Market Share by Region (2017-2022)
Figure 27. Global Meropenem Injection Revenue Market Share by Country/Region in 2021
Figure 28. Americas Meropenem Injection Sales 2017-2022 (K Units)
Figure 29. Americas Meropenem Injection Revenue 2017-2022 ($ Millions)
Figure 30. APAC Meropenem Injection Sales 2017-2022 (K Units)
Figure 31. APAC Meropenem Injection Revenue 2017-2022 ($ Millions)
Figure 32. Europe Meropenem Injection Sales 2017-2022 (K Units)
Figure 33. Europe Meropenem Injection Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Meropenem Injection Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Meropenem Injection Revenue 2017-2022 ($ Millions)
Figure 36. Americas Meropenem Injection Sales Market Share by Country in 2021
Figure 37. Americas Meropenem Injection Revenue Market Share by Country in 2021
Figure 38. United States Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Meropenem Injection Sales Market Share by Region in 2021
Figure 43. APAC Meropenem Injection Revenue Market Share by Regions in 2021
Figure 44. China Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Meropenem Injection Sales Market Share by Country in 2021
Figure 51. Europe Meropenem Injection Revenue Market Share by Country in 2021
Figure 52. Germany Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Meropenem Injection Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Meropenem Injection Revenue Market Share by Country in 2021
Figure 59. Egypt Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Meropenem Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Meropenem Injection in 2021
Figure 65. Manufacturing Process Analysis of Meropenem Injection
Figure 66. Industry Chain Structure of Meropenem Injection
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...